<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03128567</url>
  </required_header>
  <id_info>
    <org_study_id>C 14-01</org_study_id>
    <nct_id>NCT03128567</nct_id>
  </id_info>
  <brief_title>Deep Brain Stimulation for Patients With Parkinson's Disease.</brief_title>
  <acronym>STTARTLATE</acronym>
  <official_title>Effets de la Stimulation cérébrale Profonde Chez Les Patients âgés Avec Maladie de Parkinson : Essai contrôlé randomisé Multicentrique</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut National de la Santé Et de la Recherche Médicale, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Deep brain stimulation of the sub thalamic nucleus (STN-DBS) is an efficient treatment to
      improve motor and non motor signs of Parkinson's disease (PD). In people aged more 70 years,
      an increased rate of side effects such as post-operative cognitive decline and/or postural
      instability with falls has been suspected with less improvement in the quality of life. Here,
      Investigators aim further explore the effects of STN-DBS in 50 patients with PD people aged
      more 69 years in a randomized parallel controlled study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The effects of combined bilateral deep brain stimulation of the subthalamic nucleus and
      medical treatment on the quality of life will be evaluated in 25 PD patients aged more 69
      years in comparison to 25 PD patients aged more 69 years that only received medical drug
      treatment.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 2017</start_date>
  <completion_date type="Anticipated">March 2021</completion_date>
  <primary_completion_date type="Anticipated">January 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>Quality of life</measure>
    <time_frame>Quality of life one year after surgery</time_frame>
    <description>PDQ-39 scale</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Parkinson Disease</condition>
  <arm_group>
    <arm_group_label>Stimulation of the subthalamic nucleus</arm_group_label>
    <description>25 patients with Parkinson's disease</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Best medical treatment</arm_group_label>
    <description>25 patients with Parkinson's disease</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Stimulation of the subthalamic nucleus</intervention_name>
    <description>Stimulation of the subthalamic nucleus</description>
    <arm_group_label>Stimulation of the subthalamic nucleus</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Parkinson's disease
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Parkinson's disease

          -  disease duration &gt; 5 years

          -  levodopa related motor complications

          -  dopasensitivity &gt; 50%

          -  signed informed written consent

          -  medical social insurance

        Exclusion Criteria:

          -  dementia

          -  contra-indication to neurosurgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>69 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 23, 2017</study_first_submitted>
  <study_first_submitted_qc>April 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 25, 2017</study_first_posted>
  <last_update_submitted>June 1, 2017</last_update_submitted>
  <last_update_submitted_qc>June 1, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 2, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

